FDA: Mylan plant probe to continue

The FDA's investigation of Mylan's quality-control practices at a Morgantown, WV plant will continue for a "few weeks," an agency spokesman told the Dominion Post. The statement comes after Mylan chief Robert Coury backpedaled on his previous claims that FDA had wrapped up the probe. Report 

Suggested Articles

It’s final: England won’t be covering AZ’s quick-selling Tagrisso in previously untreated non-small cell lung cancer patients with EGFR mutatations.

Top J&J meds have managed to hang onto market share in the face of new generics and biosims, but the drugmaker expects the pain to continue in 2020.

Lonza’s search for a new CEO is expected to be wrapped up this year as the CDMO homes in on a list of veterans from outside the company.